Analysis of clinical features, treatment, and prognosis of primary Xlymphoepithelioma-like carcinoma of the lung

• Published in: European review for medical and pharmacological sciences Vol. 26; no. 24; p. 9416
• Main Authors: Hu, H-Y, Long, L, Dai, S-A, Yan, G-Q, Huang, Y, He, J
• Format: Journal Article
• Language: English
• Published: Italy 01-12-2022
• Subjects: Carcinoma, Squamous Cell; Epstein-Barr Virus Infections; Female; Herpesvirus 4, Human - genetics; Humans; Lung - pathology; Lung Neoplasms - diagnosis; Lung Neoplasms - genetics; Lung Neoplasms - therapy; Male; Prognosis; Retrospective Studies
• ISSN: 2284-0729
• DOI: 10.26355/eurrev_202212_30693

Primary pulmonary lymphoepithelioma-like carcinoma (PPLELC) is a rare lung malignancy occurring most frequently in young non-smokers from Southeast Asia. Given its low incidence, PPLELC clinical features, treatment methods, and the factors affecting its prognosis remain elusive. To date, PPLELC data are mainly derived from clinical case reports, and no cohort studies are available. Therefore, we retrospectively analyzed a group of PPLELC cases and summarized the clinical features of patients, treatment responses, and the factors affecting patient prognosis.
A total of 91 patients having primary pulmonary lymphoepithelioma-like carcinoma were recruited in this study. These included sex, age, place of birth, smoking history, pre-treatment symptoms, tumor location, tumor markers, maximum tumor diameter, treatment regimen, lymph node presence metastasis after an operation, pathological picture, immunohistochemistry, genetic findings, and tumor stage grading. We determined the overall survival (OS), progression-free survival (PFS), basic clinical characteristics, treatment option, treatment response, and recurrence pattern among the patients. In addition, we understood the influence of sex, age, tumor, nodes, and metastases (TNM) stage, tumor size, and surgery over patient prognosis.
Primary pulmonary lymphoepithelioma-like carcinoma is more common among young non-smokers, with a slightly higher incidence in women than in men. The expression of Epstein-Barr virus-encoded small RNA (EBER), pancytokeratin (PCK), Cytokeratin 5/6 (CK5/6), and tumor protein 63 (P63) was positive in immunohistochemistry. Serum cytokeratin 19 fragment antigen (CYFRA21-1) and Epstein-Barr DNA (EB-DNA) could be used as markers to diagnose primary pulmonary lymphoepithelioma-like carcinoma. TNM stage and surgery were independent prognostic factors.
Primary pulmonary lymphoepithelioma-like carcinoma is rare, showing a good prognosis.